Uneingeschränkter Zugang

Follow-Up of Neuropsychological Development During the First Postnatal Year in Infants with Neonatal Jaundice


Zitieren

1. Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. Wood AJJ, editor. N Engl J Med. 2001;344(8):581-90.10.1056/NEJM200102223440807Search in Google Scholar

2. Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162(3):477-82.10.1016/j.jpeds.2012.08.022Search in Google Scholar

3. Slancheva B, Krasteva M, Georgieva R, Mumdjiev Hr. Neonatologya. Laxbook, Plovdiv. 2018; 714-741. Bulgarian.Search in Google Scholar

4. Agrawal V, Goyal AK, Sharma JN, Yadav MD. Different causes of prolonged unconjugated Jaundice in the newborns. International Journal of Contemporary Pediatrics. 2017;4(3):984.10.18203/2349-3291.ijcp20171712Search in Google Scholar

5. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med. 2006;354(18):1889-900.10.1056/NEJMoa054244Search in Google Scholar

6. Ordinance No. 2 on the organization and verification of preventive examinations in persons from 0 to 18 years and dispensary monitoring of carefully health insured persons of February 4, 2003, State Gazette № 4 of January 16, 2004. Bulgarian.Search in Google Scholar

7. Olusanya BO, Kaplan M, Hansen TWR. Neonatal hyperbilirubinaemia: a global perspective. Lancet Glob Health. 2018;2(8):610-20.10.1016/S2352-4642(18)30139-1Search in Google Scholar

8. Wu YW, Kuzniewicz MW, Wickremasinghe AC, Walsh EM, Wi S, McCulloch CE, et al. Risk for cerebral palsy in infants with total serum bilirubin levels at or above the exchange transfusion threshold. JAMA Pediatrics. 2015;169(3):239.10.1001/jamapediatrics.2014.303625560920Search in Google Scholar

9. Shapiro S, Le Pichon JB, Riordan SM, Watchkoe J. The neurological sequelae of neonatal hyperbilirubinemia: definitions, diagnosis and dreatment of the dernicterus spectrum disorders (KSDs). Current Pediatric Reviews. 2017;13.10.2174/157339631366617081510021428814249Search in Google Scholar

10. Olds C, Oghalai JS. Audiologic impairment associated with bilirubin-induced neurologic damage. Semin Fetal Neonat M. 2015;20(1):42-6.10.1016/j.siny.2014.12.006431495425575899Search in Google Scholar

11. Hokkanen L, Launes J, Michelsson K. Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates – a 30-year prospective follow-up study. Peer J. 2014;2:e294.10.7717/peerj.294396114824688870Search in Google Scholar

12. Lv M, Zhang H, Shu Y, Chen S, Hu Y, Zhou M. The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China. Transl. Neurosci. 2016;7(1).10.1515/tnsci-2016-0002501759128123815Search in Google Scholar

13. Kuzniewicz MW, Niki H, Walsh EM, McCulloch CE, Newman TB. Hyperbilirubinemia, phototherapy, and childhood asthma. Pediatrics. 2018;142(4):e20180662.10.1542/peds.2018-066230209075Search in Google Scholar

14. Ramy N, Ghany EA, Alsharany W, Nada A, Darwish RK, Rabie WA, et al. Jaundice, phototherapy and DNA damage in full-term neonates. J Perinatol. 2015;36(2):132-6.10.1038/jp.2015.16626583945Search in Google Scholar

15. Yahia S, Shabaan AE, Gouida M, El-Ghanam D, Eldegla H, El-Bakary A et al. Influence of hyperbilirubinemia and phototherapy on markers of genotoxicity and apoptosis in full- term infants. Eur J Pediatr. 2014;174(4):459-64.10.1007/s00431-014-2418-z25209224Search in Google Scholar

16. Krishna H, Changil A, Srinivas M, Roy TS, Jacob TG. Ultrastructural study of rat testis following conventional phototherapy during neonatal period. J Microsc Ultrastruct. 2018;6(4):205-11.Search in Google Scholar

17. Kanmaz HG, Okur N, Dilli D, Yesilyurt A, Oguz SS. The effect of phototherapy on sister chromatid exchange with different light density in newborn hyperbilirubinemia. Turk Pediatri Ars. 2018;52(4):202-7.10.5152/TurkPediatriArs.2017.5143581985729483799Search in Google Scholar

eISSN:
1313-9053
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
2 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, andere, Augenheilkunde, Öffentliches Gesundheitswesen, Pharmazie, Klinische Pharmazie